:

Alessia Lozito1, Maria Gemelli2, Donata Micello3

  • 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, 20090, Italy.

Immunotherapy
|July 11, 2023
PubMed
概括

免疫检查点抑制剂,如PD-1/PDL-1阻断剂,可以引起与免疫相关的不良事件. 这份报告详细介绍了一个罕见的巨头的病例,可能与这种癌症免疫疗法有关.